CollPlant Biotechnologies (CLGN) Short-term Investments (2018 - 2025)

CollPlant Biotechnologies' Short-term Investments history runs 8 years deep, the most recent figure standing at $359000.0 for Q4 2025.

• Quarterly Short-term Investments fell 99.86% year-over-year to $359000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $359000.0 (down 99.86% YoY) and the FY2025 annual result came in at $359000.0, down 99.86% from the prior year.
• Short-term Investments was $359000.0 for Q4 2025 at CollPlant Biotechnologies, up from $273000.0 in the prior quarter.
• Across five years, Short-term Investments topped out at $213.0 billion in Q4 2021 and bottomed at $178000.0 in Q2 2021.
• A 5-year average of $11.9 billion and a median of $257000.0 in 2023 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2021 — Short-term Investments soared 117679458.01% — and 2022, when it sank 99.91%.
• CollPlant Biotechnologies' Short-term Investments stood at $213.0 billion in 2021, then sank by 99.91% to $188.0 million in 2022, then tumbled by 99.87% to $241000.0 in 2023, then soared by 102804.56% to $248.0 million in 2024, then plunged by 99.86% to $359000.0 in 2025.
• Business Quant data shows CLGN's Short-term Investments at $359000.0 in Q4 2025, $273000.0 in Q2 2025, and $248.0 million in Q4 2024.